ArticleCancer management and research2019

Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties.

Anna Wawruszak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.